A new trading day began on Monday, with Vir Biotechnology Inc (NASDAQ: VIR) stock price up 7.75% from the previous day of trading, before settling in for the closing price of $5.68. VIR’s price has ranged from $4.16 to $14.45 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -18.74%. Meanwhile, its annual earnings per share averaged 9.04%. With a float of $93.09 million, this company’s outstanding shares have now reached $139.02 million.
Vir Biotechnology Inc (VIR) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 33.09%, while institutional ownership is 54.23%. The most recent insider transaction that took place on Nov 17 ’25, was worth 37,782. In this transaction EVP & Chief Financial Officer of this company sold 6,799 shares at a rate of $5.56, taking the stock ownership to the 110,701 shares. Before that another transaction happened on Nov 17 ’25, when Company’s Officer proposed sale 6,799 for $5.56, making the entire transaction worth $37,781.
Vir Biotechnology Inc (VIR) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.76 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.14% during the next five years compared to -18.74% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Here are Vir Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 50.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.62, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.93 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
The latest stats from [Vir Biotechnology Inc, VIR] show that its last 5-days average volume of 1.62 million was superior to 1.54 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 66.87%.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 81.88%, which indicates a significant decrease from 87.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was higher than the 0.31 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.64, while its 200-day Moving Average is $5.83. Now, the first resistance to watch is $6.39. This is followed by the second major resistance level at $6.67. The third major resistance level sits at $7.02. If the price goes on to break the first support level at $5.76, it is likely to go to the next support level at $5.41. The third support level lies at $5.13 if the price breaches the second support level.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
With a market capitalization of 851.45 million, the company has a total of 139,125K Shares Outstanding. Currently, annual sales are 74,210 K while annual income is -521,960 K. The company’s previous quarter sales were 240 K while its latest quarter income was -163,140 K.
